Back to results
US 2013/0273103 A1Published application
Polyvalent immunogen
AssigneesLos Alamos National Security, LLC, Duke University
InventorsHua-xin Liao, Alan S. Lapedes, Barton F. Haynes, Bette T. Korber
Life of this patent
Estimating the term…
Abstract
The present invention relates, in general, to HIV-1 and, in particular, to polyvalent immunogens suitable for use in inducing an immune response to HIV-1 in a patient, and to methods of identifying such immunogens. The invention further relates to methods of inducing an anti-HIV-1 immune response using such immunogens.
Claims16
A polyvalent immunogen comprising gp140 Envs:
- i) B.0040, B.6240 and C.089,
- ii) B.0040, B.6240 and B.62357,
- iii) CONS, B.0040 and B.6240, or
- iv) CON.S, 8.0040 and C.089.
1 more element
A polyvalent immunogen comprising gp140 ENVS:
- i) CON.S, B.63521, B.0040, B.62357, B.6240, and C.089, or
- ii) CON.S, A1.con.env.03.140CF, C.con.env.03.140CF, CON.T, 8.0040 and C.089.
Use of a polyvalent immunogen comprising gp140 Envs:
- i) B.0040, B.6240 and 0.089,
- ii) B.0040, B.6240 and B.62357.
- iii) CON.S, B.0040 and B.6240, or
- iv) CONS, B.0040 and C.089,
- or nucleotide sequence, or nucleotide sequences, encoding said polyvalent immunogen,
- for inducing an immune response against HIV-1 in a subject.
3 more elements
Use of a polyvalent immunogen comprising gp140 Envs:
- i) CON.S, B.63521, B.0040, B.62357, B.6240, and C.089, or
- ii) CON.S, Al .con.env.03.140CF, C.con.env.03.140CF, CON.T, 8.0040 and C.089,
- or nucleotide sequence, or nucleotide sequences, encoding said polyvalent immunogen,
- for inducing an immune response against HIV-1 in a subject.
1 more element
Dependencies are inferred from the claim text.